山外山跌3.83% 2022年上市募11.7亿西部证券保荐

Group 1 - The stock of Shanwaishan (688410.SH) closed at 11.05 yuan, with a decline of 3.83%, currently in a state of breaking issue [1] - Shanwaishan was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 26, 2022, with an issuance of 36.19 million shares at a price of 32.30 yuan per share [1] - The total amount raised from the initial public offering (IPO) was 1.16893 billion yuan, with a net amount of 1.06711 billion yuan after deducting issuance costs, which was 179.63 million yuan less than the original plan [1] Group 2 - Shanwaishan's IPO funds were intended for projects including blood purification equipment and high-value consumables industrialization, blood purification R&D center construction, marketing network upgrades, and working capital supplementation [1] - The total issuance costs for the IPO amounted to 101.83 million yuan, with the underwriting fee being 75.14 million yuan [1] - In 2023, Shanwaishan announced a cash dividend of 0.20 yuan per share and a capital reserve increase of 0.49 shares per share, resulting in a total distribution of 43.13 million yuan in cash dividends and 105.67 million shares after the increase [2]

SWS Medical-山外山跌3.83% 2022年上市募11.7亿西部证券保荐 - Reportify